Armata Pharmaceuticals, Inc. 8-K

Shareholder vote

Shareholders backed annual executive-pay votes and ratified Ernst & Young as FY2026 auditor.

Filed 2026-06-16 16:43 ET

Summary

Shareholder vote. Shareholders elected seven directors for one-year terms, approved named executive officer compensation and annual advisory votes on compensation, and ratified Ernst & Young LLP as auditor for FY2026. The board will continue annual compensation votes until the next required vote on frequency or a different frequency is determined.

The summary is written by an AI model reading the filing.

Model 005 · prompt 01d34d48e3

Feedback